Bide Pharmatech (688073) Stock Overview
Engages in the research, development, production, and sale of pharmaceutical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
688073 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Bide Pharmatech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥66.16 |
| 52 Week High | CN¥82.88 |
| 52 Week Low | CN¥34.30 |
| Beta | 0.84 |
| 1 Month Change | -11.08% |
| 3 Month Change | -11.47% |
| 1 Year Change | 37.49% |
| 3 Year Change | 17.11% |
| 5 Year Change | n/a |
| Change since IPO | 37.40% |
Recent News & Updates
Shareholder Returns
| 688073 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -5.4% | -1.2% | 0.3% |
| 1Y | 37.5% | 12.0% | 16.8% |
Return vs Industry: 688073 exceeded the CN Pharmaceuticals industry which returned 12% over the past year.
Return vs Market: 688073 exceeded the CN Market which returned 16.8% over the past year.
Price Volatility
| 688073 volatility | |
|---|---|
| 688073 Average Weekly Movement | 7.9% |
| Pharmaceuticals Industry Average Movement | 4.3% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 688073's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 688073's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 129 | Lan Dai | www.bidepharmatech.com |
Bide Pharmatech Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. Its products are used in life sciences, organic chemistry, analytical chemistry, and other applications. The company was founded in 2007 and is based in Shanghai, China.
Bide Pharmatech Co., Ltd. Fundamentals Summary
| 688073 fundamental statistics | |
|---|---|
| Market cap | CN¥5.70b |
| Earnings (TTM) | CN¥153.31m |
| Revenue (TTM) | CN¥1.27b |
Is 688073 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688073 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.27b |
| Cost of Revenue | CN¥746.96m |
| Gross Profit | CN¥522.79m |
| Other Expenses | CN¥369.48m |
| Earnings | CN¥153.31m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.78 |
| Gross Margin | 41.17% |
| Net Profit Margin | 12.07% |
| Debt/Equity Ratio | 9.6% |
How did 688073 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/15 00:59 |
| End of Day Share Price | 2025/12/15 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bide Pharmatech Co., Ltd. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kai Wang | Citic Securities Co., Ltd. |
| Xiao Wei Lin | Everbright Securities Co. Ltd. |
| Yuan Yuan Sun | Industrial Securities Co. Ltd. |